FinancialContent is the trusted provider of stock market information to the media industry.
Latest News about Denali Therapeutics Inc/
Genentech kills big drug study in early Alzheimer's patients
January 30, 2019
Another Bay Area biotech files plans to go public
January 08, 2019
Peninsula Alzheimer's fighter hunts $150 million IPO
January 07, 2019
category Allogene Therapeutics Inc/ (South San Francisco CA) , Ultragenyx Pharmaceutical Inc/ , Allogene Therapeutics, Inc/ , and 28 more.
Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs
December 10, 2018
Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics
November 26, 2018
Eyeing faster path for sickle cell drug, Peninsula biotech plots expansion — for a higher price
November 08, 2018
Big pharma leases almost 500,000 square feet for new research center
November 01, 2018
category Alphabet Inc/ , Merck & Company, Inc/ , Alexandria Real Estate Equities, Inc/ , and 12 more.
Why Big Pharma is finally discovering the Bay Area
May 23, 2018
'Bursting at the seams,' this high-profile Peninsula biotech company is moving to a bigger home
May 21, 2018
category Cbre Group, Inc/ (Los Angeles, CA) , Autodesk, Inc/ , Greenberg Traurig, LLP (New York, NY) , and 133 more.
Kilroy snags South S.F. biotech project, home to 23andMe labs
January 31, 2018
Redwood City biopharma startup hopes to raise up to $98M in what could be Bay Area's first IPO of 2018
December 28, 2017